Approval · Notice of Compliance 1880 · 1999
REFLUDAN: Notice of Compliance 1880
Issued October 1, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1880
- Date
- October 1, 1999
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antithrombotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REFLUDAN | 02240996 | Cancelled Post Market |
Medicinal ingredients
- LEPIRUDIN 50 MG per VIAL